Esperion Therapeutis.Inc. buy nadine86
Start price
11.05.23
/
50%
€1.37
Target price
11.06.23
-
Performance (%)
-6.13%
End price
12.06.23
€1.29
Summary
This prediction ended on 12.06.23 with a price of €1.29. With a performance of -6.13%, the BUY prediction by nadine86 finished with a loss. nadine86 has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | 2.803% | 2.803% | 61.002% |
| iShares Core DAX® | -0,82 % | -2,03 % | 9,73 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % | -0,86 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % | 27,79 % |
| iShares S&P 500 | -1,17 % | -3,46 % | 0,10 % |
Comments by nadine86 for this prediction
In the thread Trading Esperion Therapeutis.Inc.
Die von nadine86 gewählte maximale Laufzeit wurde überschritten